<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        0505257335
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2008
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        RELESTAT 0.05% EYE DROPS
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        EPINASTINE HYDROCHLORIDE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        0.05
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Ophthalmic use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Eye drops, solution
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Dropper Container
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        OTC
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        26.2
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="ALLERGAN PHARMACEUTICALS LTD" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            ALLERGAN PHARMACEUTICALS LTD
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 359]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Cigalah Group
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            ABBVIE LIMITED
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        S01GX10
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Relestat is an anti-allergic medicine.</p><p>It is an eye drops solution used to treat the <strong>symptoms </strong>of seasonal <strong>allergic conjunctivitis</strong>, a seasonal allergic disease affecting the eye. The main symptoms treated by Relestat include watery eyes and eyes or eyelids which are itchy, red or swollen.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not use Relestat:</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>if you are allergic </strong>to epinastine hydrochloride or any of the other ingredients of this medicine (listed in Section 6).</p><p><strong>&nbsp;</strong></p><p><strong>Warnings and precautions</strong></p><p>Talk to your doctor or pharmacist before using Relestat.</p><p><strong>&nbsp;</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>if you wear soft contact lenses</strong>: you must remove them before using the Relestat eye drops. After using Relestat, wait at least 15 minutes before putting your lenses back in. See also in Section 2, &ldquo;Relestat contains benzalkonium chloride&rdquo;.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>if you have to use any other eye drops during treatment with Relestat</strong>: leave at least 10 minutes between putting in Relestat and the other drops.</p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>Other medicines and Relestat</strong></p><p>Tell your doctor or pharmacist if you are using, have recently used or might use any other medicines.</p><p>&nbsp;</p><p>If you have to use any other eye drops during treatment with Relestat, please see above under &ldquo;Warnings and precautions&rdquo; in this section.</p><p><strong>&nbsp;</strong></p><p><strong>Pregnancy and breast-feeding </strong></p><p><strong><u>&nbsp;</u></strong></p><p><u>Pregnancy</u></p><p>If you are pregnant, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine.</p><p><strong>&nbsp;</strong></p><p><u>Breast-feeding</u></p><p>It is not known whether Relestat passes into breast milk. Ask your doctor or pharmacist for advice before using this medicine during breast-feeding.</p><p><strong>&nbsp;</strong></p><p><strong>Driving and using machines</strong></p><p>Your sight may become blurred for a short time just after using Relestat. You should not drive or use machines until your sight is clear again.</p><p><strong>&nbsp;</strong></p><p><strong>Relestat contains benzalkonium chloride</strong></p><p>Relestat contains a preservative, called benzalkonium chloride, that can discolour soft contact lenses and may cause eye irritation.</p><p>&nbsp;</p><p>If you wear soft contact lenses (also called hydrophilic lenses) you must remove them before using the Relestat eye drops. After using Relestat, you have to wait at least 15 minutes before putting your lenses back in.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always use this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.</p><p>&nbsp;</p><p><strong>Use in children</strong></p><p>Relestat should not be used in children below 12 years of age.</p><p>&nbsp;</p><p><strong>Use in adults and adolescents (12 years of age and older)</strong></p><p>&nbsp;</p><p>The recommended dose is <strong>1 drop </strong>in <strong>each eye </strong>that needs treatment, <strong>twice a day</strong>, for example in the morning and in the evening.</p><p>&nbsp;</p><p>You should use Relestat every day that you experience eye symptoms during the allergy season but for <strong>no longer than 8 weeks</strong>.</p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>Instructions for use</strong></p><p>You must not use the bottle if the tamper-proof seal on the bottle neck is broken before you first begin to use it.&nbsp; Apply your eye drops in the following way:</p><p><img alt="" width="580" height="242" src="data:image/png;base64,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" /></p><p><br />1. Wash your hands.&nbsp; Tilt your head back and look at the ceiling.</p><p>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Gently pull the lower eyelid down until there is a small &ldquo;pocket&rdquo;.</p><p>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turn the bottle upside down and squeeze it to release one drop into each eye that needs treatment.</p><p>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Let go of the lower lid, and close your eye for 30 seconds.</p><p>&nbsp;</p><p>If a drop misses your eye, try again.</p><p>To avoid contamination of the solution in the bottle, do not let the tip of the dropper touch your eye or anything else.</p><p>Replace and tighten the cap straight after use.</p><p>Wipe off any excess liquid from your cheek with a clean tissue.</p><p>&nbsp;</p><p>The proper application of your eye drops is very important.&nbsp; If you have any questions ask your doctor or pharmacist.</p><p>&nbsp;</p><p><strong>If you use more Relestat than you should</strong></p><p>If you use more drops of Relestat than you should<strong>, </strong>it is unlikely to cause you any harm. Put your next drop(s) in at the usual time. If you are worried, talk to your doctor or pharmacist.</p><p><strong>&nbsp;</strong></p><p><strong>If you forget to use Relestat</strong></p><p>If you forget a dose apply it as soon as you remember, unless it is almost time for your next dose, in which case you should miss out the forgotten dose. Then, use your next dose at the usual time and continue with your normal routine.</p><p>&nbsp;</p><p>Do not use a double dose to make up for a forgotten dose.</p><p>&nbsp;</p><p><strong>If you stop using Relestat</strong></p><p>Relestat should be used as advised by your doctor.&nbsp;</p><p>If you have any further questions on the use of this medicine, ask your doctor or pharmacist.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them. None of the side effects are likely to be serious; most side effects are likely to be mild and only affect the eye.</p><p>&nbsp;</p><p>If the following happens, stop using Relestat and contact your doctor immediately or go to your nearest hospital:</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; asthma (an allergic disease affecting the lungs that causes breathing difficulties)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you experience symptoms of angioedema (swelling of face, tongue or throat; difficulty&nbsp;&nbsp;</p><p>&nbsp;&nbsp;&nbsp;&nbsp; swallowing; hives and breathing difficulties)</p><p>&nbsp;</p><p>The following side effects may also occur:</p><p><strong>&nbsp;</strong></p><p><strong>Common </strong>(may affect up to 1 in 10 people)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; burning sensation or irritation of the eye (mostly mild)</p><p><strong>&nbsp;</strong></p><p><strong>Uncommon </strong>(may affect up to 1 in 100 people)</p><p>&nbsp;</p><p><u>General side effects:</u></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; headache</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; swelling and irritation inside the nose, which may cause a runny or blocked nose and sneezing</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; unusual taste in your mouth</p><p>&nbsp;</p><p><u>Side effects affecting the eye:</u></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; red eyes</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; dry eyes</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; itchy eyes</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; difficulty in seeing clearly</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; discharge from the eyes</p><p>&nbsp;</p><p><u>Not known (frequency cannot be estimated from the available data):</u></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; increased tear production</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; eye pain</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; allergic reaction affecting the eyes</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; swelling of the eyes</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; swelling of the eyelids</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; skin rash and redness</p><p>&nbsp;</p><p><strong>Other side effects reported with eye drops containing phosphate</strong></p><p>In very rare cases, some patients with severe damage to the clear layer at the front of the eye (the cornea) have developed cloudy patches on the cornea due to calcium build-up during treatment.</p><p>&nbsp;</p><p><strong>Reporting of side effects</strong></p><p>If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in 6 .</p><p>&nbsp;</p><p>&nbsp;</p><p>By reporting side effects you can help provide more information on the safety of this medicine.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep this medicine out of the sight and reach of children.</p><p>&nbsp;</p><p>Do not use this medicine after the expiry date which is stated on the label of the bottle and on the box after EXP.</p><p>&nbsp;</p><p>Do not use this medicine if you notice that the eye drops have shown signs of deterioration, for example change in colour, and take the product back to your pharmacist.</p><p>&nbsp;</p><p>Do not store above 30&deg;C.</p><p>&nbsp;</p><p>Keep the bottle in the box in order to protect from light.</p><p>&nbsp;</p><p>You must <strong>throw away the bottle 28 days after you first opened it</strong>, even if there are still some drops left. This will guard against infection. To help you remember, write down the date that you opened it in the space on the box.</p><p>&nbsp;</p><p>&nbsp;</p><p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>What Relestat contains</strong></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The active substance is epinastine hydrochloride. One ml of eye drops, solution, contains</p><p>0.5 mg of epinastine hydrochloride.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The other ingredients are benzalkonium chloride (a preservative), disodium edetate, sodium chloride, sodium dihydrogen phosphate dihydrate, sodium hydroxide/hydrochloric acid (to adjust pH) and purified water.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Relestat is a clear and colourless eye drops solution in a plastic bottle with a screw-cap. When unopened, each bottle is about half full and contains 5 ml of solution.
Each pack contains 1 bottle.


            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Manufacturer</strong></p><p>Allergan Pharmaceuticals Ireland</p><p>Castlebar Road</p><p>Westport</p><p>County Mayo</p><p>Ireland</p><p><strong>&nbsp;</strong></p><p><strong>Marketing Authorization Holder</strong></p><p>AbbVie Limited</p><p>Citywest Business Campus</p><p>Dublin 24</p><p>Ireland</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last revised in August 2018.
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">ريلستات عبارة عن دواء مضاد للحساسية.</p><p dir="RTL">محلول قطرة للعين يستخدم لعلاج <strong>أعراض</strong> <strong>التهاب الملتحمة التحسسي</strong> الموسمي، و هو أحد أمراض الحساسية الموسمية التي تصيب العين. الأعراض الأساسية التي يتم علاجها عن طريق ريلستات تشمل تدميع العين و حكة أو احمرار أو تورم العينين أو الجفنين.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>لا تستخدم ريلستات:</strong></p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>اذا كنت مصاب بحساسية </strong>تجاه هيدروكلوريد الإبيناستين أو تجاه أي من المكونات الأخرى لهذا الدواء ( المذكورة في البند رقم 6).</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>التحذيرات و الاحتياطات</strong></p><p dir="RTL">تحدث مع طبيبك الخاص أو الصيدلي قبل استخدام ريلستات.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>اذا كنت ترتدي العدسات اللاصقة اللينة: </strong>يجب عليك نزعها قبل استخدام قطرة العين ريلستات. عقب استخدام ريلستات، انتظر لمدة 15 دقيقة على الأقل قبل وضع العدسات مرة أخرى. انظر أيضاً البند رقم 2، &quot; ريلستات يحتوي على كلوريد البنزالكونيوم&quot;.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>اذا كنت تستخدم أي قطرة أخرى للعين خلال العلاج مع ريلستات: </strong>اترك 10 دقائق على الأقل ما بين وضع ريلستات و استخدام القطرة الأخرى.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>الأدوية الأخرى و ريلستات</strong></p><p dir="RTL">أبلغ طبيبك الخاص أو الصيدلي اذا كنت تستخدم، أو قمت مؤخراً باستخدام، أو ربما استخدمت أي أدوية أخرى.</p><p dir="RTL">اذا كنت مضطر لاستخدام أي قطرة أخرى خلال العلاج مع ريلستات، برجاء النظر أعلاه تحت&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &quot;التحذيرات و الإحتياطات&quot; في هذا البند.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الحمل و الرضاعة</strong></p><p dir="RTL"><strong><u>الحمل</u></strong></p><p dir="RTL">اذا كنت حاملاً، أو تظنين إنك ربما تكونين حاملاً أو اذا كنت تخططين للحمل، استشيري طبيبك الخاص أو الصيدلي قبل استخدام هذا الدواء.</p><p dir="RTL"><strong><u>&nbsp;</u></strong></p><p dir="RTL"><strong><u>الرضاعة</u></strong></p><p dir="RTL">ليس من المعروف ما إن كان ريلستات ينفذ إلى لبن الأم. استشيري طبيبك الخاص أو الصيدلي قبل استخدام هذا الدواء أثناء الرضاعة.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>القيادة و استخدام الآلات</strong></p><p dir="RTL">ربما تتعرض لغشاوة بالإبصار لمدة قصيرة مباشرةً عقب استخدام ريلستات, يجب عليك الإمتناع عن القيادة أو استخدام الآلات حتى اتضاح الرؤية مرة أخرى.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>ريلستات يحتوي على كلوريد البنزالكونيوم</strong></p><p dir="RTL">ريلستات يحتوي على مادة حافظة، تسمى كلوريد البنزالكونيوم، و التي يمكن أن تغير من لون العدسات اللاصقة اللينة و قد تسبب تهيج العين.</p><p dir="RTL">&nbsp;</p><p dir="RTL">اذا كنت ترتدي عدسات لاصقة لينة ( تسمى أيضاً العدسات الأليفة للماء) يجب عليك نزعها قبل استخدام قطرة ريلستات. عقب استخدام ريلستات، يجب عليك الإنتظار لمدة 15 دقيقة على الأقل قبل وضع العدسات مرة أخرى.</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">استخدم هذا الدواء دائماً على النحو الذي وصفه لك الطبيب تماماً. يمكنك إستشارة طبيبك الخاص أو الصيدلي اذا لم تكن متأكداً.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الاستخدام في الأطفال</strong></p><p dir="RTL">لا يجب استخدام ريلستات في الأطفال الذين يبلغون أقل من 12 عام.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الإستخدام في البالغين و المراهقين ( 12 عام أو أكبر)</strong></p><p dir="RTL">الجرعة الموصى بها تبلغ <strong>نقطة واحدة</strong> <strong>بكل عين</strong> تحتاج للعلاج، <strong>مرتين في اليوم</strong>، على سبيل المثال في الصباح و في المساء.</p><p dir="RTL">يجب عليك استخدام ريلستات في كل يوم تشعر فيه بأعراض بالعين خلال موسم الحساسية لكن <strong>ليس لمدة أطول من 8 أسابيع.</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>تعليمات الإستخدام</strong></p><p dir="RTL">لا يجب عليك إستعمال الزجاجة اذا كان الختم المقاوم للعبث على عنق الزجاجة مكسور و ذلك قبل أن تبدأ في استخدامها للمرة الاولى. ضع القطرة بالطريقة التالية:</p><p><img alt="" width="580" height="242" src="data:image/png;base64,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" /></p><p>&nbsp;</p><p dir="RTL">1-&nbsp;&nbsp;&nbsp;&nbsp; اغسل يديك. أمل رأسك للخلف و انظر للسقف.</p><p dir="RTL">2-&nbsp;&nbsp;&nbsp;&nbsp; قم بجذب الجفن السفلي لأسفل حتى يظهر &quot;جيب&quot; صغير.</p><p dir="RTL">3-&nbsp;&nbsp;&nbsp;&nbsp; اقلب الزجاجة رأساً على عقب و اضغط عليها لإنزال نقطة واحدة أو نقطتين داخل كل عين تحتاج للعلاج.</p><p dir="RTL">4-&nbsp;&nbsp;&nbsp;&nbsp; اترك الجفن السفلي و اغلق عينك لمدة 30 ثانية.</p><p dir="RTL">&nbsp;</p><p dir="RTL">اذا سقطت نقطة بعيداً عن عينك، حاول مرة أخرى.</p><p dir="RTL">&nbsp;</p><p dir="RTL">لتجنب تلوث المحلول بداخل الزجاجة، لا تدع طرف القطارة يلمس عينك أو أي شىء آخر.</p><p dir="RTL">ضع الغطاء و احكم اغلاقه عقب الاستخدام مباشرةً.</p><p dir="RTL">امسح أي زيادة من السائل من على خدك باستخدام منديل نظيف.</p><p dir="RTL">&nbsp;</p><p dir="RTL">الاستخدام السليم لقطرة العين الخاصة بك يعتبر أمر في غاية الأهمية. اذا كان لديك أية أسئلة، يمكنك سؤال طبيبك الخاص أو الصيدلي.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>اذا استخدمت </strong><strong>ريلستات أكثر مما ينبغي</strong></p><p dir="RTL">لو وضعت نقط من ريلستات أكثر مما ينبغي، لن يتسبب ذلك على الأرجح في أي ضرر بالنسبة لك. ضع النقطة (النقط) التالية في الميعاد المعتاد. اذا شعرت بقلق، ناقش الأمر مع طبيبك الخاص أو الصيدلي.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>اذا نسيت استخدام </strong><strong>ريلستات</strong></p><p dir="RTL">اذا نسيت جرعة ضعها بمجرد أن تتذكر إلا لو كان الوقت قد حان تقريباً لأخذ جرعتك التالية، و في هذه الحالة يجب عليك تخطي الجرعة المنسية. ثم قم باستخدام جرعتك التالية في الوقت المعتاد مع مواصلة روتينك العادي.</p><p dir="RTL">&nbsp;</p><p dir="RTL">لا تأخذ جرعة مضاعفة لتعويض الجرعة المنسية.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>اذا توقفت عن استخدام ريلستات</strong></p><p dir="RTL">ينبغي استخدام ريلستات على النحو الموصوف من جانب طبيبك الخاص.</p><p dir="RTL">اذا كان لديك أي أسئلة أخرى بخصوص استخدام هذا الدواء، اسأل طبيبك الخاص أو الصيدلي.</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">شأنه شأن الأدوية الأخرى، هذا الدواء يمكن أن يسبب آثاراً جانبية، لكن قد لا يصاب الجميع بها. ليس من المرجح أن تكون أياً من هذه الآثار الجانبية خطيرة؛ معظم الآثار الجانبية غالباً ما تكون خفيفة و تصيب العين فقط.</p><p dir="RTL">&nbsp;</p><p dir="RTL">اذا حدث التالي، توقف عن استخدام ريلستات و اتصل بطبيبك الخاص فوراً أو اذهب لأقرب مستشفى:</p><ul><li dir="RTL">الربو ( مرض حساسية يصيب الرئتين و يسبب صعوبات في التنفس)</li><li dir="RTL">&nbsp;إذا واجهت أعراض الوذمة الوعائية (تورم في الوجه أو اللسان أو الحلق ؛ صعوبة &nbsp;البلع ، الشرى وصعوبة التنفس)</li></ul><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>قد تحدث الآثار الجانبية التالية:</strong></p><p dir="RTL"><strong>شائعة</strong> ( قد تصيب ما يصل إلى 1 من كل 10 أشخاص)</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; احساس بالحرقان أو تهيج بالعين ( غالباً خفيف).</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>غير شائعة</strong> ( قد تصيب ما يصل إلى 1 من كل 100 شخص)</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong><u>&nbsp;</u></strong></p><p dir="RTL"><strong><u>&nbsp;</u></strong></p><p dir="RTL"><strong><u>الآثار الجانبية العامة</u></strong></p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; صداع</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تورم و تهيج داخل الأنف، مما قد يسبب رشح أو انسداد الأنف و العطس.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طعم غير عادي في الفم</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong><u>الآثار الجانبية التي تصيب العين</u></strong></p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; احمرار العينين</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; جفاف العينين</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حكة العينين</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; صعوبة الرؤية بوضوح</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; افرازات من العين</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong><u>غير معروف (لا يمكن تقدير التكرار من البيانات المتاحة):</u></strong></p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة في افراز الدموع</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم بالعين</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الحساسية التي تؤثر على العينين</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تورم العينين</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تورم الجفون</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفح و احمرار الجلد</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>آثار جانبية أخرى تم الإبلاغ عنها مع قطرة العين التي تحتوي على فوسفات</strong></p><p dir="RTL">في حالات نادرة للغاية، بعض المرضى المصابين بتلف شديد بالطبقة الشفافة في الجزء الأمامي من العين ( القرنية) ظهرت لديهم بقع غائمة على القرنية نتيجة لتراكم الكالسيوم خلال العلاج.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الإبلاغ عن الآثار الجانبية</strong></p><p dir="RTL">اذا أصبت بأي من الآثار الجانبية، تحدث مع طبيبك الخاص أو الصيدلي أو الممرضة. يشمل ذلك أي آثار جانبية لم يرد ذكرها في هذه النشرة, يمكنك أيضاً الإبلاغ عن الآثار الجانبية مباشرة عن طريق</p><p dir="RTL">&nbsp;&nbsp;&nbsp;&nbsp; الهيئات الصحية المحلية.</p><p dir="RTL">&nbsp;&nbsp;&nbsp;&nbsp; بالإبلاغ عن الآثار الجانبية، يمكن أن تساعد في توفير مزيد من المعلومات حول سلامة هذا الدواء.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يحفظ هذا الدواء بعيداً عن مرأى و متناول الأطفال.</p><p dir="RTL">&nbsp;</p><p dir="RTL">لا تستخدم هذا الدواء بعد تاريخ انتهاء الصلاحية المذكور على البطاقة اللاصقة الخاصة بالزجاجة و على العلبة الخارجية بعد EXP.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">لا تستخدم هذا الدواء في حالة ظهور علامات التلف على القطرة، على سبيل المثال تغير في اللون، و قم بإرجاعها مرة أخرى للصيدلي.</p><p dir="RTL">&nbsp;</p><p dir="RTL">تخزن في درجة حرارة لا تتجاوز 30 ْم.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">احتفظ بالزجاجة داخل العلبة من أجل حمايتها من الضوء.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">يجب عليك<strong> التخلص من الزجاجة بعد 28 يوم من فتحها للمرة الأولى، </strong>حتى في حالة وجود بعض النقط المتبقية. سوف يحميك ذلك من العدوى. لمساعدتك على التذكر، قم بتدوين تاريخ فتح الزجاجة على العلبة.</p><p dir="RTL">&nbsp;</p><p dir="RTL">لا تقم بالقاء أي أدوية عبر مياه الصرف الصحي أو النفايات المنزلية. اسأل الصيدلي عن كيفية التخلص من الأدوية التي لم تعد مستخدمة. سوف تساعد هذه التدابير على حماية البيئة.</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>&nbsp;&nbsp;&nbsp;&nbsp; ما الذي يحتوي عليه ريلستات</strong></p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المادة الفعالة هي هيدروكلوريد الإبيناستين، 1 ملليلتر من محلول قطرة العين يحتوي على 0.5 مجم من هيدروكلوريد الإبيناستين.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المكونات الأخرى هي كلوريد البنزالكونيوم ( مادة حافظة)، إيديتات ثنائي الصوديوم، كلوريد الصوديوم، ثنائي هيدرات فوسفات دايهيدروجين الصوديوم، هيدروكسيد الصوديوم / حمض الهيدروكلوريك (لضبط الأس الهيدروجيني) و ماء نقي.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>كيف يبدو ريلستات و محتويات العبوة</strong></p><p dir="RTL">ريلستات عبارة عن محلول قطرة للعين شفاف و عديم اللون في زجاجة بلاستيكية ذات غطاء لولبي. قبل فتحها، تكون كل زجاجة ممتلئة تقريباً للنصف و تحتوي على 5 ملليلتر من المحلول.</p><p dir="RTL">كل عبوة تحتوي على زجاجة واحدة.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>&nbsp;&nbsp;&nbsp; المصنع</strong></p><p dir="RTL">أليرجان فارماسيوتيكالس أيرلندا</p><p dir="RTL">كاسلبار رود</p><p dir="RTL">وستبورت</p><p dir="RTL">كونتي مايو</p><p dir="RTL">أيرلندا</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الشركة المسوقة</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">أبفي ليمتد</p><p dir="RTL">سيتي ويست بزنس كامبوس</p><p dir="RTL">دبلن ٢٤</p><p dir="RTL">أيرلندا</p><p dir="RTL"><strong>&nbsp;</strong></p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تمت المراجعة الأخيرة لهذه النشرة في اغسطس 2018
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Relestat, 0.5 mg/ml, eye drops, solution.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                One ml of eye drops, solution, contains 0.5 mg of epinastine hydrochloride.
(equivalent to 0.436 mg epinastine)

Excipient(s) with known effect: benzalkonium chloride 0.1 mg/ml

For the full list of excipients, see section 6.1.


            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Eye drops, solution.  
A clear colourless sterile solution.


            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Treatment of the symptoms of seasonal allergic conjunctivitis.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Posology </u></p><p>&nbsp;</p><p>The recommended dose for adults is one drop instilled in each affected eye twice daily, during the symptomatic period.</p><p>&nbsp;</p><p>There is no experience in clinical studies with the use of Relestat for more than 8&nbsp;weeks.</p><p>&nbsp;</p><p><em>Older people</em></p><p>Relestat has not been studied in older people.&nbsp; Post-marketing safety data from the tablet formulation of epinastine hydrochloride (up to 20 mg once daily) indicates that there are no particular safety issues for older people compared with adult patients.&nbsp; As such, no dosage adjustment is considered to be necessary.</p><p>&nbsp;</p><p><em>Paediatric population</em></p><p>&nbsp;</p><p>The safety and efficacy in children &ge; 12 years has been established in clinical trials.&nbsp; Relestat may be used in adolescents (12 years of age and older) at the same dosage as in adults.</p><p><u>&nbsp;</u></p><p>The safety and efficacy of Relestat in children aged less than 3 years have not been established.&nbsp; No data are available. There are limited data on the safety in children aged 3-12 years, described in section 5.1.</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p><em>Patients with hepatic<u> </u>impairment</em></p><p>&nbsp;</p><p>Relestat has not been studied in patients with hepatic impairment.&nbsp; Post‑marketing safety data from the tablet formulation of epinastine hydrochloride (up to 20 mg once daily) indicates that the incidence of adverse reactions was higher in this group compared with adult patients without hepatic impairment.&nbsp; The daily dose of a 10 mg epinastine hydrochloride tablet is more than 100-fold higher than the daily dose following Relestat.&nbsp; In addition, the metabolism of epinastine in humans is minimal (&lt;10%).&nbsp; Therefore, no dosage adjustment is considered to be necessary.</p><p>&nbsp;</p><p><em>Patients with renal<u> </u>impairment</em></p><p>&nbsp;</p><p>Relestat has not been studied in patients with renal impairment.&nbsp; Post‑marketing safety data from the tablet formulation of epinastine hydrochloride (up to 20 mg once daily) indicate that there are no particular safety issues for patients with renal impairment.&nbsp; As such, no dosage adjustment is considered to be necessary.</p><p>&nbsp;</p><p><u>Method of Administration</u></p><p>&nbsp;</p><p>Relestat is for topical ophthalmic use only.</p><p>&nbsp;</p><p>To avoid contamination of the eye or eye drops do not allow the dropper tip to come into contact with any surface.</p><p>&nbsp;</p><p>If more than one topical ophthalmic medicinal product is being used, the different medicinal products should be administered at least 10&nbsp;minutes apart.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Relestat is for topical ophthalmic use only and not for injection or oral use.</p><p>&nbsp;</p><p>Benzalkonium chloride is commonly used as a preservative in ophthalmic products and has been reported rarely to cause punctate keratopathy and/or toxic ulcerative keratopathy.</p><p><u>&nbsp;</u></p><p>Benzalkonium chloride may be absorbed by and discolour soft contact lenses and therefore patients should be instructed to wait until 10-15 minutes after instillation of Relestat before inserting contact lenses.&nbsp; Relestat should not be administered while wearing contact lenses.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No interaction studies have been performed.</p><p>No drug-drug interactions are anticipated in humans since systemic concentrations of epinastine are extremely low following ocular dosing.&nbsp; In addition, epinastine is mainly excreted unchanged in humans indicating a low level of metabolism.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Pregnancy</u></p><p>&nbsp;</p><p>Data on a limited number (11) of exposed pregnancies indicate no adverse effects of epinastine on pregnancy or on the health of the foetus/newborn child.&nbsp; To date, no other relevant epidemiological data are available.&nbsp; Animal studies do not indicate direct or indirect harmful effects with respect to pregnancy, embryonic/foetal development, parturition or postnatal development (see section 5.3).</p><p>&nbsp;</p><p>Caution should be exercised when prescribing to pregnant women.</p><p>&nbsp;</p><p><u>Breast-feeding</u></p><p>Epinastine is excreted in the breast milk of rats, but it is not known if epinastine is excreted in human milk.&nbsp; Due to the lack of experience, caution should be exercised when prescribing to breast-feeding women.</p><p><u>&nbsp;</u></p><p><u>Fertility</u></p><p><u>&nbsp;</u></p><p>There are no adequate data from the use of epinastine on fertility in humans.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Based on the pharmacodynamic profile, reported adverse reactions and specific psychometric studies, Relestat has no or negligible influence on the ability to drive and use machines.</p><p>&nbsp;</p><p>If transient blurred vision occurs at instillation, the patient should wait until the vision clears before driving or using machinery.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Summary of the Safety profile</u></p><p><em>&nbsp;</em></p><p>In clinical studies, the overall incidence of adverse drug reactions following Relestat was less than 10%.&nbsp; No serious adverse reactions occurred.&nbsp; Most were ocular and mild.&nbsp; The most common adverse reaction was burning sensation in eye (mostly mild); all other adverse reactions were uncommon.</p><p>&nbsp;</p><p><u>Tabulated list of adverse reactions</u></p><p>&nbsp;</p><p>Within each frequency grouping, adverse reactions are presented according to System Organ Class in order of decreased seriousness.&nbsp; The following terminologies have been used in order to classify the occurrence of undesirable effects: Very common (&ge;1/10); common (&ge;1/100 to &lt;1/10); uncommon (&ge;1/1,000 to &lt;1/100); rare (&ge;1/10,000 to &lt;1/1,000); very rare (&lt;1/10,000); not known (cannot be estimated from the available data).</p><p>&nbsp;</p><p>The following adverse drug reactions were reported during clinical trials with Relestat:</p><p>&nbsp;</p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0" style="width:600px"><tbody><tr><td style="vertical-align:top"><p><strong>System Organ Class</strong></p></td><td style="vertical-align:top"><p><strong>Frequency</strong></p></td><td style="vertical-align:top"><p><strong>Adverse Reaction</strong></p><p><strong>&nbsp;</strong></p></td></tr><tr><td style="vertical-align:top"><p>Nervous system disorders</p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Headache</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>Eye disorders</p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Burning sensation, eye irritation</p></td></tr><tr><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Conjunctival/ocular hyperaemia, eye discharge, eye dryness, eye pruritus, visual disturbance</p></td></tr><tr><td style="vertical-align:top"><p>Respiratory, thoracic and mediastinal disorders</p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Asthma, nasal irritation, rhinitis</p></td></tr><tr><td style="vertical-align:top"><p>Gastrointestinal disorders</p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Dysgeusia</p></td></tr></tbody></table><p>&nbsp;</p><p>&nbsp;</p><p>The following adverse drug reactions were reported during post marketing use of epinastine in clinical practice:</p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0" align="left" style="width:628px"><tbody><tr><td style="vertical-align:top"><p><strong>System Organ Class</strong></p></td><td style="vertical-align:top"><p><strong>Frequency</strong></p></td><td style="vertical-align:top"><p><strong>Adverse Reaction</strong></p></td></tr><tr><td style="vertical-align:top"><p>Immune system disorders</p></td><td style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p><u>Hypersensitivity reaction including symptoms or signs of eye allergy and extra-ocular allergic reactions, including angioedema, skin rash and redness</u></p></td></tr><tr><td style="vertical-align:top"><p>Eye disorders</p></td><td style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>Increased lacrimation, eye pain, <u>eye swelling, eyelid oedema</u></p></td></tr></tbody></table><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p><u>Paediatric population</u></p><p>&nbsp;</p><p>Frequency, type and severity of adverse reaction in adolescents &ge; 12 years of age are expected to be the same as in adults.</p><p>There is limited experience in children aged 3-12 years regarding frequency, type and severity of adverse reactions.</p><p>&nbsp;</p><p><u>Adverse reactions reported in phosphate containing eye drops</u></p><p>Cases of corneal calcification have been reported very rarely in association with the use of phosphate containing eye drops in some patients with significantly damaged corneas.</p><p>&nbsp;</p><p><u>Reporting of suspected adverse reactions</u></p><p>Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via:</p><p>To report any side effects(s)</p><p>&bull;&nbsp;&nbsp;&nbsp;Saudi Arabia:</p><p>-&nbsp;&nbsp; The National Pharmacovigilance Centre (NPC)</p><p>- SFDA Call Center: 19999</p><p>- E-mail: npc.drug@sfda.gov.sa&nbsp; &nbsp;</p><p>- Website: https://ade.sfda.gov.sa/</p><p>&nbsp;</p><p>&nbsp; Other GCC States:</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>-&nbsp; Please contact the relevant competent authority.</p></td></tr></tbody></table><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>After instillation of 0.3% epinastine hydrochloride eye drops 3 times daily (corresponds to 9 times the recommended daily dose) reversible miosis, without influence on visual acuity or other ocular parameters, was observed.&nbsp;</p><p>&nbsp;</p><p>The 5 ml bottle of Relestat contains 2.5 mg of epinastine hydrochloride. A tablet formulation is marketed at a once daily dose of up to 20 mg epinastine hydrochloride, as such, intoxication after oral ingestion of the ophthalmic formulation is not expected even if the whole content of the bottle is swallowed.</p><p>&nbsp;</p><p>No case of overdose has been reported.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Ophthalmologicals; Decongestants and Antiallergics; Other antiallergics</p><p>ATC code: S01G X10</p><p>&nbsp;</p><p><u>Mechanism of action</u></p><p>&nbsp;</p><p>&nbsp;</p><p>Epinastine is a topically active, direct H<sub>1</sub>-receptor antagonist.&nbsp; Epinastine has a high binding affinity for the histamine H<sub>1</sub>-receptor and a 400 times lower affinity for the histamine H<sub>2</sub>-receptor.&nbsp; Epinastine also possesses affinity for the a<sub>1</sub>-, a<sub>2</sub>-, and the 5-HT<sub>2</sub> &ndash;receptor.&nbsp; It has low affinity for cholinergic, dopaminergic and a variety of other receptor sites.&nbsp; Epinastine does not penetrate the blood/brain barrier and, therefore, does not induce side effects of the central nervous system, i.e., it is non-sedative.</p><p>&nbsp;</p><p><u>Pharmacodynamic effects </u></p><p>Following topical eye application in animals, epinastine showed evidence for antihistaminic activity, a modulating effect on the accumulation of inflammatory cells, and mast cell stabilising activity.</p><p>&nbsp;</p><p>In provocation studies with allergens in humans, epinastine was able to ameliorate ocular symptoms following ocular antigen challenge.&nbsp; The duration of the effect was at least 8&nbsp;hours.<br />&nbsp;</p><p>Paediatric population</p><p>&nbsp;</p><p>A 6-week, randomised, double-masked, vehicle controlled study (2:1) involving 96 ocular-wise non-symptomatic, healthy children aged 3-12 years, indicated that Relestat was well tolerated and did not identify any significant differences between the groups for any safety variable. Treatment related reactions were conjunctival follicles (6.3% in both epinastine and vehicle-treated subjects) and conjunctival hyperaemia (1.6% of epinastine treated subjects and none in the vehicle group). Safety and efficacy in patients &ge; 12 years has been established in clinical trials.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Absorption</u></p><p>Following administration of one drop of Relestat in each eye twice daily, an average maximum plasma concentration of 0.042 ng/ml is reached after about two hours.</p><p><u>Distribution</u></p><p>Epinastine has a volume of distribution of 417 litres and is 64% bound to plasma proteins.</p><p><u>Biotransformation</u></p><p>Less than 10% is metabolised.</p><p><u>Elimination</u></p><p>The clearance is 928 ml/min and the terminal plasma elimination half-life is about 8 hours.</p><p>Epinastine is mainly excreted renally unchanged.&nbsp; The renal elimination is mainly via active tubular secretion.</p><p>Preclinical studies <em>in vitro</em> and <em>in vivo</em> show that epinastine binds to melanin and accumulates in the pigmented ocular tissues of rabbits and monkeys.&nbsp; <em>In vitro</em> data indicate that the binding to melanin is moderate and reversible.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Non clinical data revealed no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity, genotoxicity, carcinogenic potential toxicity to reproduction and development.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Benzalkonium chloride,</p><p>Disodium edetate,</p><p>Sodium chloride,</p><p>Sodium dihydrogen phosphate dihydrate,</p><p>Sodium hydroxide/hydrochloric acid (pH adjustment),</p><p>Purified water.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                2 years.

After first opening: 4 weeks.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Keep the bottle in the outer carton in order to protect from light.</p><p>Do not store above 30&deg;C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>10 ml polyethylene bottle with a white polystyrene screw cap.</p><p>The fill volume is 5 ml.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements.</p><p>Any unused medicinal product or waste material should be disposed of in accordance with local requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                AbbVie Limited 
Citywest Business Campus
Dublin 24
Ireland

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                October  2018
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>